- Import Intent
France is an import-only country — no domestic commercial cultivation for medical use. All medicinal cannabis must be imported under ANSM authorization per shipment. EU-GMP Part I required — France is EEA; ANSM issues EU-GMP certificates.
- ANSM import authorization per shipment
- Importer must hold ANSM wholesale authorization (autorisation de commerce de gros)
- EU-GMP Part I mandatory
- Importer Holds ANSM Wholesale Authorization — Autorisation de commerce de gros
Importer must already hold ANSM wholesale dealer authorization. This is a prerequisite before applying for per-shipment import authorizations.
- ANSM wholesale authorization
- GDP compliance
- Narcotic storage and handling authorization
- Apply: ANSM Per-Shipment Import Auth
Per-shipment import authorization application to ANSM. Products must be on the authorized list or covered by an ATU. INCB reporting required.
- EU-GMP Part I certificate
- COA per batch
- Exporting country export authorization
- Product on authorized list or ATU documentation
- Processing: approximately 4–8 weeks
- Authorization granted?
ANSM reviews and issues or requests clarification. Common issues: product not on authorized list, GMP certificate scope, or incomplete ATU documentation.
- French Customs Entry
EU customs procedures apply. Pharmaceutical-grade cannabis cleared for delivery to authorized importer.
- ANSM import authorization (original)
- All shipping documentation
- EU customs narcotic declaration
- INCB reporting completed
- Cleared for French Market ✓
Pharmaceutical-grade cannabis released to authorized importer. QP batch release required before supply to hospital/community pharmacies.